OFI Advisors’s Gilead Sciences GILD Stock Holding History

OFI Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$2.21M	Sell	22,465 -349	-2%	-$38.8K	0.14%	142
2015 Q2	$2.67M	Buy	22,814 +973	+4%	+$106K	0.16%	131
2015 Q1	$2.14M	Buy	21,841 +3,215	+17%	+$326K	0.13%	152
2014 Q4	$1.76M	Buy	18,626 +3,144	+20%	+$325K	0.11%	178
2014 Q3	$1.65M	Sell	15,482 -2,818	-15%	-$276K	0.12%	170
2014 Q2	$1.52M	Buy	18,300 +3,053	+20%	+$238K	0.11%	182
2014 Q1	$1.08M	Buy	15,247 +212	+1%	+$16.6K	0.08%	252
2013 Q4	$1.13M	Buy	15,035 +179	+1%	+$12.5K	0.09%	220
2013 Q3	$934K	Sell	14,856 -1,675	-10%	-$100K	0.09%	222
2013 Q2	$848K	Buy	+16,531	New	+$862K	0.09%	231

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OFI Advisors's GILD Position: Q3 2015 in Review

OFI Advisors reduced its Gilead Sciences (GILD) stake by 1.5% in Q3 2015, selling an estimated $38.8K and leaving 22,465 shares worth $2.21M. The position accounts for 0.14% of the portfolio, ranked #142.

OFI Advisors first reported a position in GILD in Q2 2013 and has held it in 10 quarters since. The position peaked at $2.67M in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

OFI Advisors held 22,465 shares of Gilead Sciences worth $2.21M as of Q3 2015.
OFI Advisors sold 349 Gilead Sciences shares in Q3 2015, an estimated $38.8K.
Gilead Sciences made up 0.14% of OFI Advisors's portfolio in Q3 2015, its #142 holding.
OFI Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Gilead Sciences position peaked at $2.67M in Q2 2015.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.